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Introduction Stenting after pyeloplasty is an established
practice and helps in ensuring a patent anastomosis until
healing has completed. Stents, however, may cause
complications such as infection and displacement and
increase the cost of management; therefore, stentless
pyeloplasty is now considered as feasible alternative.
Patients and methods From August 2008 to October 2010,
we retrospectively analyzed the results of stentless surgery
in patients with ureteropelvic junction (UPJ) obstruction. In all,
42 patients with UPJ obstruction were managed. Nine patients
who were treated conservatively, one who underwent
nephrectomy, and one pyelostomy for pyonephrosis in solitary
kidney were excluded. Age range at surgery was 14 days–12
years with a mean age of 12.7 months.
Results There were 23 male patients and eight female
patients with a male-to-female ratio of 3 : 1. Fourteen patients
had left, 12 right, and five had bilateral UPJ obstruction. A total
of 34 pyeloplasties were performed in 31 patients. Of the
five patients with bilateral UPJ obstruction, three underwent
bilateral pyeloplasty and remaining two underwent unilateral
pyeloplasty with conservative management on the opposite
sides. Two patients underwent laparoscopic pyeloplasties and
32 pyeloplasties by open technique. Double J stent was
placed at initial surgery in three patients and 31 stentless
pyeloplasties were performed. The mean operative time was
75 min. The mean perinephric drain removal time was 2 days.
None of the patients had persistent urinary leak. The mean
hospital stay was 3.2 days. Reduction in anteroposterior
diameter was noticed in 91% cases on 12 weeks follow-up
scan. Complications included persistent or increase in
hydronephrosis in three (9%) patients. In all the three patients,
cystoscopic stenting was attempted. In two patients, size 4 Fr
double J stent was passed easily into the renal pelvis. One
patient improved, whereas other still has a dilated pelvis
with static anteroposterior diameter after removal of stent at
6 weeks; patient is kept on close surveillance on regular
ultrasonography. Re-exploration was performed in one
patient, which showed kinking at the anastomosis site.
Pyeloplasty was revised and patient improved. Other
complications included lumbar hernia in one patient, which
improved at 6-month follow-up, and stitch granuloma in one
patient, which improved after removal of residual stitch.
Conclusion Stentless surgery for UPJ obstruction is
a safe and feasible technique; it reduces the cost of
surgery and avoids multiple procedures. Ann Pediatr Surg
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Introduction
Stenting has remained a standard practice for achieving
optimal results of pyeloplasty [1]. Stents have the
disadvantage of infections, displacements, breakage, and
increased cost of surgery [1,2]. The fear with stentless
pyeloplasty is anastomosis dehiscence, leakage, and higher
incidence of stricture formation. It has been shown by
various studies that the incidence of complications by
stented and stentless pyeloplasty may be similar results [3,4].
Stentless pyeloplasty has the advantage of less hospital stay,
avoidance of a second procedure, and decreased cost of
surgery. Studies have proved the safety and efficacy of
stentless pyeloplasty in open, laparoscopic, and robotic-
assisted pyeloplasties [4,5]. We retrospectively reviewed our
results of stentless pyeloplasty with a view to evaluate the
safety, efficacy, and cost effectiveness of stentless pyeloplasty
in children and to compare the incidence of complications
and outcome of surgery with other published studies.
Patients and methods
From October 2008 to October 2010, we retrospectively
reviewed patients who underwent stentless pyeloplasty
for ureteropelvic junction (UPJ) obstruction. The pur-
pose was to evaluate the safety, efficacy, and cost
effectiveness of stentless pyeloplasty in children. All
patients underwent ultrasonography (US) and MAG-III
scan for preoperative and postoperative evaluation of
UPJ. Patients were divided into mild, moderate, and
severe category on the basis of anteroposterior (AP)
diameter and split renal function. All patients having AP
diameter of more than 20 mm and split renal function
of less than 35% were operated. Patients having AP
diameter of less than 15 and split function of more than
40 were placed on conservative treatment. Patients lying
in the gray area were operated, if they had breakthrough
infections or were symptomatic. Informed consent was
taken from all patients regarding the procedure. Dis-
membered Anderson Hynes pyeloplasty was performed
through posterolateral extraperitoneal approach. Two
patients underwent laparoscopy-assisted pyeloplasty.
Pyeloplasty was performed using 6/0 or 7/0 polydioxanone
suture over a 5 or 6 Fr feeding tube, which was removed at
the completion of anastomosis. Stents were placed in only
three patients with very large pelvis. All other patients
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underwent stentless pyeloplasty. A perinephric drain was
placed in all patients, which was removed when urinary
drainage stopped. All patients had uretheral catheteriza-
tion for 24 h. A follow-up ultrasound scan was performed
at 6 weeks and 3 months. A cystoscopic double J stent
was placed in patients after stentless pyeloplasty who had
increase in AP diameter of renal pelvis after surgery at
3-month follow-up. One patient needed re-exploration
with progressive hydronephrosis, as it was not possible to
pass the double J stent cystoscopically.
Results
A total of 42 patients were managed during this period. Of
these, nine patients who were on conservative treatment,
one who underwent nephrectomy for nonfunctioning
kidney, and one who underwent nephrostomy for solitary
kidney with UPJ obstruction and pyonephrosis were
excluded from the study. Age range at surgery was 14
days–12 years with a mean age of 12.7 months. In all, 71%
patients were below 1 year of age. There were 23 male
patients and eight female patients with a male-to-female
ratio of about 3 : 1. Fourteen patients had left, 12 right, and
five had bilateral UPJ obstruction. Associated anomalies
included posterior urethral valves in one patient. A total of
34 pyeloplasties were performed in 31 patients. Of the five
patients with bilateral UPJ obstruction, three underwent
bilateral pyeloplasties and remaining two underwent uni-
lateral pyeloplasty with conservative management on the
opposite sides. Two patients underwent laparoscopic-
assisted pyeloplasty and 32 pyeloplasties by open technique.
Double J stent was placed at initial surgery in three patients
and were excluded. All other patients underwent stentless
pyeloplasty (31 pyeloplasties). The mean operative time
was 75 min. The mean perinephric drain removal time was 2
days. None of the patients had persistent urinary leak. The
mean hospital stay was 3.2 days. Reduction in AP diameter
was noticed in 91% cases on 12 weeks follow-up scan.
Average preoperative AP diameter was 35.9 mm that
reduced to 21.8 mm at follow-up. Complications included
increase in hydronephrosis in three (9%) patients. Cysto-
scopic stenting was attempted in all three patients. In two
patients, size 4 Fr double J stent was passed easily into the
renal pelvis. One patient improved but the other still has a
dilated pelvis with static AP diameter after removal of stent
at 6 weeks; patient is kept on close surveillance on regular
US. Re-exploration was performed in one patient, which
showed kinking at the anastomosis site. Pyeloplasty was
revised and patient improved. Other complications included
lumbar hernia in one patient, which improved at 6-month
follow-up, and stitch granuloma in one patient, which
improved after removal of residual stitch. Cost of surgery to
the patients for stentless and stented pyeloplasty was about
800 and 1300 dollars, respectively, in private setup. In the
public hospital, it was much less due to the state sponsor of
the patients.
Discussion
Stenting the anastomosis after pyeloplasty for UPJ
obstruction has remained a standard procedure with
excellent results [3]. Stenting keeps the anastomosis
patent until healing has completed. It also minimizes the
risk for leakage, obstruction, and adhesions after pyelo-
plasty. Various forms of stent have been used for this
purpose, the most popular being double J stent that is
usually removed through cystoscopy, 2–4 weeks after
surgery [6]. Stents are also available for office removal
such as feedings tubes, ureteric catheters, and purpose-
built stents such as kidney internal splintage stent [7].
Although the stents help in achieving the results of a good
pelviureteric anastomosis, they have some disadvantages
such as cost of stent, removal under anesthesia, and
complications such as infection, displacement, breakage,
stone formation, prolapse, etc. [4,8]. With the improve-
ment in the surgical techniques and the availability of
better suture material, the previously feared complications
of stentless pyeloplasty, such as stricture, leakage, urinoma
formation, adhesions, and recurrence, can now be avoided
in most cases. We compared our results with other studies
for parameters of hospital stay, recurrence, complications,
and redo-surgery [2,9,10]. It can be seen that incidence of
complications is comparable with other studies where
stents were used after pyeloplasty (Fig. 1). The use of
stents may result in more secondary procedures than
stentless pyeloplasty [2]. Urinary leakage is a significant
concern in patients who undergo stentless pyeloplasty.
None of our patients had a persistent leak after stentless
pyeloplasty. The key in achieving these results is to
preserve the vascularity of the ureter and the renal pelvis.
This can be achieved by keeping the adventitia along with
the ureter and the renal pelvis intact. The other important
factor is meticulous spatulated anastomosis with fine
sutures avoiding thick bites. A comparative analysis of the
preoperative and postoperative AP diameter suggests
significant decrease in AP diameter that is comparable
with other studies (Fig. 2) [2,3,5,9]. We did encounter
problems in few patients. Some degree of residual
hydronephrosis is seen in most patients even after
successful surgery [11]. It takes many years before the
hydronephrosis is settled on US scan. Increase in AP
diameter of the ureters is, however, indicator of obstruction.
Three of our patients had this problem (9% of all
pyeloplasties), which is slightly higher than other stu-
dies [8,9]. Placement of stent decreased the severity of
hydronephrosis in one of the two patients. We feel that the
persistent hydronephrosis without anatomical obstruction
Fig. 1
Comparative analysis with some published studies.
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is secondary to incoordination between the renal pelvis and
ureter. Some of these patients improve with the passage of
time; however, a close surveillance with US studies shall
be performed to prevent renal damage. In one patient in
whom it was not possible to negotiate the double J stent
through the UPJ, exploration revealed that he had kinking
at the site of anastomosis. This may be one reason why a
stent may be placed after pyeloplasty.
Cost of surgery is an important consideration in the
developing countries [12]. The single most important
advantage of stentless pyeloplasty is decreased cost of
surgery. The cost of stent and removal of stent may be a
significant burden for poor patients and can be avoided
in most patients. The outcome of surgery, however, may
be different according to the severity of hydronephrosis.
In cases of very large renal pelvis, where major excision
of the redundant pelvis is performed, we were not
comfortable without placing a double J stent. Therefore,
stents were placed in three patients after pyeloplasty.
All these patients had uneventful resolution of hydrone-
phrosis.
Conclusion
It can therefore be concluded that stentless pyeloplasty is
a feasible, cost-effective, and reliable technique for
pyeloplasty in children. Secondary surgical procedures
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Fig. 2
Average anteroposterior (AP) diameter (in mm) of renal pelvis.
20 Annals of Pediatric Surgery 2015, Vol 11 No 1
Copyright © Annals of Pediatric Surgery. Unauthorized reproduction of this article is prohibited.
